Apolipoprotein E polymorphism and changes in serum lipids during a family-based counselling intervention

Public Health Nutrition

Volumn 9, Issue 7, 2006, Pages 859-865

  Salminen, Marika ^a,b   Lehtimäki, Terho ^c   Fan, Yue Mei ^c   Vahlberg, Tero ^a   Kivelä, Sirkka Liisa ^a,d,e  

^a UNIVERSITY OF TURKU   (Finland)

^b Harkatie Health Centre   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d SATAKUNTA CENTRAL HOSPITAL   (Finland)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Apolipoprotein E; Children; Cholesterol; Diet; Intervention

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; DNA POLYMORPHISM; FAMILY COUNSELING; FEEDING BEHAVIOR; FEMALE; FINLAND; FOLLOW UP; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; CHILD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIPIDS; MALE; NUTRITION PHYSIOLOGY; POLYMORPHISM, GENETIC; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES;

EID: 33846849179     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/PHN2006972     Document Type: Article

References (33)

1. Miettinen TA, Gylling H, Vanhanen H. Serum cholesterol response to dietary cholesterol and apolipoprotein E phenotype. Lancet 1988; 2: 1261.
2. Tikkanen MJ, Huttunen JK, Ehnholm C, Pietinen P. Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteriosclerosis 1990; 10: 285-8.
3. Mänttäri M, Koskinen P, Ehnholm C, Huttunen JK, Manninen V. Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. Metabolism 1991; 40: 217-21.
4. Lehtimäki T, Moilanen T, Solakivi T, Laippala P, Ehnholm C. Cholesterol-rich diet changes in plasma lipids in relation to apolipoprotein E phenotype in healthy students. Annals of Medicine 1992; 24: 61-6.
5. Kesäniemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficiency in man is related to apolipoprotein E phenotype. Journal of Clinical Investigation 1987; 80: 578-81.
6. Lala A, Scoppola A, Motti C, Caccese D, Menzinger G. Apolipoprotein E genotype and cholesterogenesis in polygenic hypercholesterolemia. Metabolism 1998; 47: 97-100.
7. Maitland-van der Zee AH, Klungel OH, Stricker BH, Verschuren MWM, Kastelein JJ, Leufkens HG, et al. Genetic-polymorphism: importance for response to HMG-CoA reductase inhibitors. Atherosclerosis 2002; 163: 213-22.
8. Mooser V, Waterworth DM, Isenhour T, Middleton L. Cardiovascular pharmacogenetics in the SNP era. Journal of Thrombosis and Haemostasis 2003; 1: 1398-402.
9. Lapinleimu H, Viikari J, Rönnemaa T, Valimaki I, Tuominen J, Marniemi J, et al. Apolipoprotein E polymorphism and serum lipids in a randomized, prospective trial of an infant diet with reduced saturated fat and cholesterol. Pediatrics 1996; 98: 757-62.
10. Tammi A, Rönnemaa T, Miettinen TA, Gylling H, Rask-Nissila L, Viikari J, et al. Effects of gender, apolipoprotein E phenotype and cholesterol-lowering by plant stanol esters in children: the STRIP study. Special Turku Coronary Risk Factor Intervention Project. Acta Paediatrica 2002; 91: 1155-62.
11. World Health Organization (WHO). International Classification of Diseases, 1975 Revision. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. Volume 1. Geneva: WHO, 1997.
12. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. Journal of Lipid Research 1990; 31: 545-8.
13. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clinical Chemistry 1977; 23: 882-4.
14. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clinical Chemistry 1982; 28: 2077-80.
15. 2. Clinical Chemistry 1983; 29: 2026-30.
16. Tietz NW. Clinical Guide to Laboratory Tests, 2nd ed. Philadelphia, PA: WB Saunders Company, 1990.
17. Friedewald WT, Levy R, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clinical Chemistry 1972; 18: 499-502.
18. Hosmer DW, Lemeshow S. Applied Logistic Regression, 2nd ed. New York: John Wiley & Sons Inc., 2000.
19. Salminen M, Vahlberg T, Ojanlatva A, Kivelä S-L. Effects of a controlled family-based health education/counseling intervention. American Journal of Health Behavior 2005; 29: 395-406.
20. Salminen M, Vahlberg T, Kivelä S-L. Effects of family-oriented risk-based prevention on serum cholesterol and blood pressure values of children and adolescents. Scandinavian Journal of Primary Health Care 2005; 23: 34-41.
21. Lehtimäki T, Moilanen T, Aalto-Setälä K, Kontula K, Porkka K, Åkerblom HK, et al. Association of apolipoprotein E and B polymorphism with serum lipids. Annals of Medicine 1991; 23: 657-62.
22. Lehtimäki T, Porkka K, Viikari J, Ehnholm C, Åkerblom HK, Nikkari T. Apolipoprotein E phenotypes and serum lipids in newborns and 3-year-old children: the Cardiovascular Risk in Young Finns Study. Pediatrics 1994; 94: 489-93.
23. Parlier G, Thomas G, Bereziat G, Fontaine JL, Girardet J. Relation of apolipoprotein E polymorphism to lipid metabolism in obese children. Pediatric Research 1997; 41: 682-5.
24. Okada T, Sato Y, Iwata F, Hara M, Kim H, Harada K. Relationship of apolipoprotein E phenotypes to serum lipid and lipoprotein levels in Japanese schoolchildren. Acta Paediatrica 1998; 87: 460-1.
25. Bercedo-Sanz A, Gonzáles-Lamuño D, Málaga S, Garcia-Fuentes M. Impact of ApoE4 allele on total cholesterol levels of children in northern Spain. Clinical Genetics 1999; 55: 69-70.
26. Couture P, Archer WR, Lamarche B, Landry N, Deriaz O, Corneau L, et al. Influences of apolipoprotein E polymorphism on the response of plasma lipids to the ad libitum consumption of a high-carbohydrate diet compared with a high-monounsaturated fatty acid diet. Metabolism 2003; 52: 1454-9.
27. Hubacek JA, Pitha J, Škodová Z, Poledne R, Lanska V, Waterworth DM, et al. Polymorphism in CYP-7A1, not APOE, influence the change in plasma lipids in response to population dietary change in an 8 year follow-up; results from the Czech MONICA study. Clinical Biochemistry 2003; 36: 263-7.
28. Ishiwata K, Homma Y, Ishikawa T, Nakamura H, Handa S. Influence of apolipoprotein E phenotype on metabolism of lipids and apolipoproteins after plant stanol ester ingestion in Japanese subjects. Nutrition 2002; 18: 561-5.
29. Ordovás JM. The genetics of serum lipid responsiveness to dietary interventions. Proceedings of the Nutrition Society 1999; 58: 171-87.
30. Dixon LB, Shannon BM, Tershakovec AM, Bennett MJ, Coates PM, Cortner JA. Effects of family history of heart disease, apolipoprotein E phenotype, and lipoprotein(a) on the response of children's plasma lipids to change in dietary lipids. American Journal of Clinical Nutrition 1997; 66: 1207-17.
31. Puska P, Vartiainen E, Pallonen U, Salonen JT, Poyhia P, Koskela K, et al. The North Karelia Youth Project: evaluation of two years of intervention on health behavior and CVD risk factors among 13- to 15-year old children. Preventive Medicine 1982; 11: 550-70.
32. Vartiainen E, Puska P, Pietinen P, Nissinen A, Leino U, Uusitalo U. Effects of dietary fat modifications on serum lipids and blood pressure in children. Acta Paediatrica Scandinavica 1986; 75: 396-401.
33. Porkka KVK, Viikari JSA, Rönnemaa T, Marniemi J, Åkerblom HK. Age and gender specific serum lipid and apolipoprotein fractiles of Finnish children and young adults. The Cardiovascular Risk in Young Finns Study. Acta Paediatrica 1994; 83: 838-48.